NewGen Announces Strategic Expansion with Services Tailored for Indian Medical Tourists
NewGen IVF Group (NASDAQ: NIVF) has announced that its subsidiary, First Fertility PGS Center, is launching specialized fertility services targeting Indian medical tourists in Thailand. The initiative includes a dedicated Indian hospitality lounge, Hindi-speaking staff, and comprehensive fertility treatments including family balance through IVF. This expansion aims to capitalize on Thailand's growing fertility tourism sector, leveraging the country's world-class medical infrastructure and visa-free entry for Indian nationals.
The strategic move aligns with significant market growth projections, as the global fertility tourism market is expected to grow from US$709 million in 2023 to US$13.08 billion by 2034, representing a 30.34% CAGR. The company's services are specifically designed to address the unique cultural and medical needs of Indian patients, offering treatments that may be restricted in their home country.
NewGen IVF Group (NASDAQ: NIVF) ha annunciato che la sua controllata, First Fertility PGS Center, sta lanciando servizi di fertilità specializzati rivolti ai turisti medici indiani in Thailandia. L'iniziativa prevede un'area accoglienza dedicata agli indiani, personale che parla hindi e trattamenti completi per la fertilità, incluso l'equilibrio familiare tramite IVF. Questa espansione mira a sfruttare il crescente settore del turismo della fertilità in Thailandia, approfittando dell'infrastruttura medica di livello mondiale del paese e dell'ingresso senza visto per i cittadini indiani.
La mossa strategica si allinea con le previsioni di forte crescita del mercato, dato che il mercato globale del turismo della fertilità dovrebbe passare da 709 milioni di dollari nel 2023 a 13,08 miliardi di dollari entro il 2034, con un CAGR del 30,34%. I servizi dell'azienda sono progettati specificamente per rispondere alle esigenze culturali e mediche uniche dei pazienti indiani, offrendo trattamenti che potrebbero essere limitati nel loro paese d'origine.
NewGen IVF Group (NASDAQ: NIVF) ha anunciado que su subsidiaria, First Fertility PGS Center, está lanzando servicios especializados de fertilidad dirigidos a turistas médicos indios en Tailandia. La iniciativa incluye un salón de hospitalidad dedicado a indios, personal que habla hindi y tratamientos integrales de fertilidad, incluyendo el equilibrio familiar mediante FIV. Esta expansión busca aprovechar el creciente sector del turismo de fertilidad en Tailandia, aprovechando la infraestructura médica de clase mundial del país y la entrada sin visa para ciudadanos indios.
Esta estrategia se alinea con las importantes proyecciones de crecimiento del mercado, ya que se espera que el mercado mundial de turismo de fertilidad crezca de 709 millones de dólares en 2023 a 13,08 mil millones de dólares para 2034, representando un CAGR del 30,34%. Los servicios de la empresa están diseñados específicamente para atender las necesidades culturales y médicas únicas de los pacientes indios, ofreciendo tratamientos que pueden estar restringidos en su país de origen.
NewGen IVF Group (NASDAQ: NIVF)는 자회사인 First Fertility PGS Center가 태국에서 인도 의료 관광객을 대상으로 한 전문 난임 치료 서비스를 시작한다고 발표했습니다. 이 이니셔티브에는 인도 전용 환대 라운지, 힌디어를 구사하는 직원, 그리고 IVF를 통한 가족 균형을 포함한 종합 난임 치료가 포함됩니다. 이번 확장은 태국의 세계적 수준의 의료 인프라와 인도 국민에 대한 무비자 입국 혜택을 활용하여 태국의 성장하는 난임 관광 시장을 공략하는 것을 목표로 합니다.
이 전략적 움직임은 글로벌 난임 관광 시장이 2023년 7억 900만 달러에서 2034년까지 130억 8천만 달러로 성장할 것이라는 중요한 시장 성장 전망과 일치하며, 이는 연평균 성장률 30.34%에 해당합니다. 회사의 서비스는 인도 환자들의 독특한 문화적 및 의료적 요구를 충족하도록 특별히 설계되었으며, 본국에서 제한될 수 있는 치료를 제공합니다.
NewGen IVF Group (NASDAQ : NIVF) a annoncé que sa filiale, First Fertility PGS Center, lance des services spécialisés en fertilité destinés aux touristes médicaux indiens en Thaïlande. L'initiative comprend un salon d'accueil dédié aux Indiens, un personnel parlant hindi et des traitements complets de fertilité, y compris l'équilibre familial via la FIV. Cette expansion vise à tirer parti du secteur croissant du tourisme de fertilité en Thaïlande, en s'appuyant sur l'infrastructure médicale de classe mondiale du pays et l'entrée sans visa pour les ressortissants indiens.
Cette démarche stratégique s'aligne sur les projections de croissance significative du marché, le marché mondial du tourisme de fertilité devant passer de 709 millions de dollars US en 2023 à 13,08 milliards de dollars US d'ici 2034, représentant un TCAC de 30,34%. Les services de l'entreprise sont spécifiquement conçus pour répondre aux besoins culturels et médicaux uniques des patients indiens, offrant des traitements qui peuvent être limités dans leur pays d'origine.
NewGen IVF Group (NASDAQ: NIVF) hat bekannt gegeben, dass seine Tochtergesellschaft First Fertility PGS Center spezialisierte Fruchtbarkeitsdienste für indische Medizintouristen in Thailand einführt. Die Initiative umfasst eine speziell eingerichtete indische Empfangslounge, Hindi-sprechendes Personal und umfassende Fruchtbarkeitsbehandlungen, einschließlich Familienbalance durch IVF. Diese Expansion zielt darauf ab, den wachsenden Fruchtbarkeitstourismus in Thailand zu nutzen, indem die erstklassige medizinische Infrastruktur des Landes und die visafreie Einreise für indische Staatsbürger ausgenutzt werden.
Dieser strategische Schritt steht im Einklang mit den bedeutenden Marktwachstumsprognosen, da der globale Markt für Fruchtbarkeitstourismus voraussichtlich von 709 Millionen US-Dollar im Jahr 2023 auf 13,08 Milliarden US-Dollar bis 2034 wachsen wird, was einer jährlichen Wachstumsrate (CAGR) von 30,34% entspricht. Die Dienstleistungen des Unternehmens sind speziell darauf ausgelegt, die einzigartigen kulturellen und medizinischen Bedürfnisse indischer Patienten zu erfüllen und Behandlungen anzubieten, die in ihrem Heimatland eingeschränkt sein könnten.
- Strategic entry into the rapidly growing fertility tourism market with 30.34% CAGR potential
- Access to Indian market through specialized services and cultural accommodations
- Competitive advantage through Thailand's progressive regulatory environment allowing treatments restricted in India
- Leveraging visa-free entry policy for Indian nationals to attract medical tourists
- High dependence on international medical tourism which can be volatile
- Potential regulatory risks if India's fertility treatment policies change
- Competition from other medical tourism destinations in Southeast Asia
Insights
NewGen's expansion targeting Indian fertility tourists leverages Thailand's regulatory advantages and projected 30% CAGR in a multi-billion dollar market.
NewGen's strategic expansion into the Indian medical tourism market represents a calculated move to capture share in a rapidly growing sector. The global fertility tourism market, valued at
Thailand offers NewGen three critical competitive advantages: first, its progressive regulatory framework permits comprehensive fertility services including family balancing through IVF (legally restricted in India); second, its advanced medical infrastructure supports high-quality care; and third, practical considerations like visa-free entry for Indian nationals reduce barriers to access.
What makes this initiative particularly strategic is NewGen's culturally-tailored approach. By establishing Hindi-speaking consultation teams, dedicated Indian hospitality lounges, and culturally familiar amenities, First Fertility is addressing a significant gap in the market. This differentiation strategy creates both switching costs and customer loyalty—two essential elements for sustainable competitive advantage in specialized healthcare services.
The timing aligns with post-pandemic trends showing accelerated growth in medical tourism, particularly for elective procedures with significant price differentials between markets. By specifically targeting Indian patients—a high-volume demographic with growing disposable income—NewGen is focusing resources on a market segment with substantial growth potential rather than attempting to compete broadly across all international patient populations.
First Fertility PGS Center Limited launches culturally tailored fertility services in Thailand's growing medical tourism sector
BANGKOK, May 27, 2025 (GLOBE NEWSWIRE) -- NewGenIvf Group Limited (NASDAQ: NIVF) (“NewGen” or the “Company”), a comprehensive fertility services provider in Asia helping couples and individuals obtain access to fertility treatments, today announced that its wholly owned subsidiary, First Fertility PGS Center Limited (“First Fertility”), has launched a strategic expansion initiative targeting the Indian medical tourism market for fertility treatments.
This initiative positions NewGen to capitalize on Thailand's rapidly growing fertility tourism sector, which has emerged as a preferred destination for international patients seeking advanced reproductive care. According to ResearchAndMarkets, the global fertility tourism market was valued at US
Building on this market opportunity, First Fertility has developed specialized services specifically designed to address the unique cultural and medical needs of Indian patients. The center now features a dedicated Indian hospitality lounge equipped with culturally familiar amenities, Hindi-speaking customer service and medical consultation teams, and comprehensive fertility treatments including family balance through IVF, which is legally available in Thailand but restricted in India. These tailored services create a comfortable, culturally sensitive environment while providing access to advanced reproductive technologies that may not be readily available in patients' home countries.
Thailand's strategic advantages as a medical tourism destination continue to drive sector growth, supported by the country's advanced healthcare infrastructure, progressive regulatory environment, and supportive tourism policies that include visa-free entry for Indian nationals. First Fertility leverages these national advantages while addressing the specific gap in culturally tailored fertility care for Indian patients, who represent a significant and underserved segment of the regional medical tourism market.
Mr. Siu Wing Fung Alfred, Founder, Chairman, and CEO of NewGen, commented, “This strategic initiative represents a natural extension of our commitment to providing world-class fertility care while capitalizing on significant market opportunities in Southeast Asia. Thailand's progressive regulatory environment, combined with our subsidiary's established expertise in fertility treatments and our new India-focused services, positions us exceptionally well to serve the growing demand from Indian medical tourists seeking advanced reproductive care in a culturally welcoming environment.”
About NewGen
NewGen is a comprehensive fertility services provider in Asia helping couples and individuals obtain access to fertility treatments. With a mission to aid couples and individuals in building families regardless of fertility challenges, NewGen has dedicated itself to creating increased access to infertility treatment and providing comprehensive fertility services for its customers. NewGen’s management team collectively has over a decade of experience in the fertility industry. NewGen’s clinics are located in Thailand, Cambodia, and Kyrgyzstan, and present a full suite of services for its patients, including comprehensive infertility and assisted reproductive technology treatments, egg and sperm donation, and surrogacy, in the appropriate jurisdictions, respectively. To learn more, visit www.newgenivf.com. The information contained on, or accessible through, NewGen’s website is not incorporated by reference into this press release, and you should not consider it a part of this press release.
Forward-Looking Statements
This press release contains forward-looking statements. These statements are made under the “safe harbor” provisions of the U.S. Private Securities Litigation Reform Act of 1995. These forward-looking statements generally are identified by the words “believe,” “project,” “expect,” “anticipate,” “estimate,” “intend,” “strategy,” “future,” “opportunity,” “plan,” “may,” “should,” “will,” “would,” “will be,” “will continue,” “will likely result,” and similar expressions. Without limiting the generality of the foregoing, the forward-looking statements in this press release include descriptions of the Company’s future service offerings, and business strategy. Forward-looking statements are predictions, projections and other statements about future events that are based on current expectations and assumptions and, as a result, are subject to risks and uncertainties. Many factors could cause actual future events to differ materially from the forward-looking statements in this press release, such as the Company’s ability to deploy its technology, identify and realize additional business opportunities and increase its market share, or changes in the regulatory or competitive environment in which the Company operates or intends to expand into. You should carefully consider the foregoing factors and the other risks and uncertainties described in the Company’s annual report on Form 20-F and other documents filed or to be filed by the Company with the SEC from time to time, which could cause actual events and results to differ materially from those contained in the forward-looking statements. Copies of these documents are available on the SEC’s website, www.sec.gov. All information provided herein is as of the date of this press release, and the Company undertakes no obligation to update any forward-looking statement, except as required under applicable law.
Investor Relations Contact
ICR, LLC
Robin Yang
Phone: +1 (212) 537-4406
Email: Newgenivf.IR@icrinc.com
FAQ
What is NewGen IVF's (NIVF) new strategic expansion initiative?
What is the projected growth of the global fertility tourism market according to NewGen (NIVF)?
What advantages does NIVF offer to Indian medical tourists in Thailand?
Why did NewGen (NIVF) choose Thailand for its Indian medical tourism expansion?
What specific services does NewGen (NIVF) offer to Indian patients in Thailand?
